Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

What is peracetic acid sterilization?

November 5, 2018 By Nancy Crotti

Vaporized peracetic acid (VPA) has become a game-changer in medical device sterilization, providing for a room-temperature process designed to preserve newer device materials and components.

Mason Schwartz, Revox Sterilization Solutions

(Image courtesy of Revox Sterilization Solutions)

Advancements in medical device manufacturing have yielded products that are either heat-sensitive or easily degradable. Many materials that would otherwise be ideal for product design cannot withstand traditional sterilization methods such as steam, dry heat, hydrogen peroxide (VHP), ethylene oxide (EtO) or gamma/E-beam irradiation. This limits overall product innovation and, if not considered before product design, interferes with project progression, objectives, and product launch.

Liquid or vapor

Peracetic acid (PAA) is formed by the reaction of acetic acid and hydrogen peroxide (H2O2); these compounds exist in equilibrium and their eventual decomposition results in oxygen (O2), carbon dioxide (CO2) and water (H2O).

The room-temperature VPA process greatly improves material compatibility over other sterilization methods such as hydrogen peroxide (VHP), ethylene oxide (EtO), and gamma/E-beam irradiation. Liquid peracetic acid (PAA) and vaporized peracetic acid (VPA) are highly biocidal sterilants that maintain efficacy in the presence of organic soil while removing surface contaminants.

Through extensive testing of more than 100 materials, VPA has shown high material compatibility. For example, the VPA method can safely sterilize products that would normally be damaged by a liquid chemical, even copper, which is known to oxidize from liquid PAA. A product containing liquid copper was exposed to the VPA process in 10 repeated four-hour cycles, only showing a slight dulling of the original gloss. Tests have also been successfully conducted using multiple sterilization cycles on thermoplastics, thermosets, adhesives, batteries, and bioabsorbables.

Bioabsorbable implants such as internal drug delivery mechanisms, stents, vascular grafts, and scaffolds for tissue engineering rank among the latest cutting-edge medical device categories in the world. They are also among the most heat- and moisture-sensitive products. Sterilizing products like these requires a stable gaseous chemical agent that will not degrade the product. The ethylene oxide (EtO) process typically operates at 40 degrees Celsius, and hydrogen peroxide gas phase sterilizers range between 28 and 60 degrees Celsius, whereas VPA sterilization processes between 18 degrees to 30 degrees Celsius.

Other advantages

VPA’s non-toxic, sterile processing solution leaves behind no harmful residuals, providing not only a safer work environment for employees but a safer product for patients. With VPA breaking down into carbon dioxide, oxygen and water, the VPA process is noncarcinogenic, nonexplosive/flammable, and requires no external ventilation. It can be integrated directly into the on-site manufacturing process, reducing transportation and inventory costs associated with other contract sterilization methods.

Sterilization process time can vary greatly, depending upon the product being sterilized and including the pre-sterilization and post-sterilization aeration periods and external quality processes. Because it requires no pre- or post-aeration, VPA can significantly reduce the overall process time and reduce inventory costs. It also provides the option to bring sterilization on-site, eliminating the inefficiencies associated with off-site sterilization.

Mason Schwartz is R&D and operations director for Revox Sterilization Solutions. He oversaw the invention of the Revox VPA sterilization method for Cantel Medical and has worked with both the FDA and Revox customers to provide support through both PMA and 510(k) submissions.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of Medical Design and Outsourcing or its employees.

Related Articles Read More >

A variety of tube-to-tube barb connectors
Qosina adds new tube-to-tube barb connectors
A portrait of Keri Mattox, Zimmer Biomet's chief communications and administration officer
Zimmer Biomet adds ESG and CEO visibility to executive’s duties
A portrait of Geoff Martha, CEO of Medtronic
‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems
A portrait of Dr. Kevin Chung, chief medical officer at SeaStar Medical
Device developer SeaStar Medical hires chief medical officer

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech